EyePoint (EYPT) Net Cash Flow (QoQ) (2010 - 2026)
EyePoint (EYPT) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -188.49% |
| Dec 31, 2025 | 693.36% |
| Sep 30, 2025 | 124.50% |
| Jun 30, 2025 | 3.65% |
| Mar 31, 2025 | -173.19% |
| Dec 31, 2024 | 281.68% |
| Sep 30, 2024 | 93.93% |
| Jun 30, 2024 | -1,658.48% |
| Mar 31, 2024 | -106.92% |
| Dec 31, 2023 | 2,358.88% |
| Sep 30, 2023 | -119.40% |
| Jun 30, 2023 | 233.91% |
| Mar 31, 2023 | -50.02% |
| Dec 31, 2022 | 399.34% |
| Sep 30, 2022 | 65.11% |
| Jun 30, 2022 | 74.81% |
| Mar 31, 2022 | -230.85% |
| Dec 31, 2021 | 843.47% |
| Sep 30, 2021 | 27.66% |
| Jun 30, 2021 | -111.69% |